Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Salt CompositionMetformin 500mg + Nateglinide 60mg
Nateglex M 60mg/500mg Tablet
You Searched
Nateglex M 60mg/500mg Tablet
Cista Medicorp
₹130
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Type 2 diabetes mellitus
Customers also bought
More About Nateglex M
Benefits
In Treatment of Type 2 diabetes mellitus Nateglex M 60mg/500mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs. Nateglex M 60mg/500mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Nateglex M 60mg/500mg Tablet is to be taken with food.
How it works
Nateglex M 60mg/500mg Tablet is a combination of two antidiabetic medicines: Nateglinide and metformin. Nateglinide is a meglitinide analogue which increases the amount of insulin released by the pancreas. This prevents blood glucose from rising very high after meals. Metformin is a biguanide which decreases the production and absorption of sugar in your body and allows better use of existing insulin. Together, they provide better control of blood sugar.
Unsafe: Avoid consuming alcohol with Nateglex M 60mg/500mg Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Nateglex M 60mg/500mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Nateglex M 60mg/500mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Caution Advised: Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Caution Advised: Nateglex M 60mg/500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Nateglex M 60mg/500mg Tablet may be needed. Doctor consultation is advised. Use of Nateglex M 60mg/500mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Caution Advised: Nateglex M 60mg/500mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Nateglex M 60mg/500mg Tablet may be needed. Doctor consultation is advised. Nateglex M 60mg/500mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Manufacturer Address
396, kamath Industrial Estate, Prabhadevi, Mumbai - 400025
References
Israel K M, Istvan E, Baron MA. Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes. Vasc Health Risk Manag. 2008;4(6):1167-78 (08 Apr. 2019)
Nateglinide. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2008 (08 Apr. 2019)
Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company; 2017 (08 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (08 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
